149 related articles for article (PubMed ID: 35411806)
1. Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study.
Zhao Y; Huang C; You H; Zhao J; Wang Q; Tian X; Zhao Y; Li M; Zeng X
Lupus; 2022 Jun; 31(7):885-890. PubMed ID: 35411806
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and risk factors of pulmonary embolism in patients with systemic lupus erythematosus: a case control study.
You H; Zhao J; Wang Q; Tian X; Li M; Zeng X
Clin Exp Rheumatol; 2020; 38(5):940-948. PubMed ID: 31969219
[TBL] [Abstract][Full Text] [Related]
3. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
[TBL] [Abstract][Full Text] [Related]
4. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study.
Chung WS; Lin CL; Chang SN; Lu CC; Kao CH
J Thromb Haemost; 2014 Apr; 12(4):452-8. PubMed ID: 24472157
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serological factors associated with lupus pericarditis: a case-control study.
Hsieh MR; Chen YF; Chang CT; Yu KH; Fang YF
Clin Rheumatol; 2023 Apr; 42(4):1061-1067. PubMed ID: 36495382
[TBL] [Abstract][Full Text] [Related]
7. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
[TBL] [Abstract][Full Text] [Related]
10. The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.
Pamuk ON; Balci MA; Donmez S; Tsokos GC
Lupus; 2016 Jan; 25(1):102-9. PubMed ID: 26345673
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study.
Xiao X; Da G; Xie X; Liu X; Zhang L; Zhou B; Li H; Li P; Yang H; Chen H; Fei Y; Tsokos GC; Zhao L; Zhang X
J Intern Med; 2021 Jul; 290(1):101-115. PubMed ID: 33259665
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
Demir S; Artim-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Omma A; Erer B; Kamalı S; Gül A; Aral O; Öcal L; İnanç M
Lupus; 2016 Feb; 25(2):177-84. PubMed ID: 26354963
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
[TBL] [Abstract][Full Text] [Related]
14. Severe pneumonia in Chinese patients with systemic lupus erythematosus.
Peng L; Wang Y; Zhao L; Chen T; Huang A
Lupus; 2020 Jun; 29(7):735-742. PubMed ID: 32403979
[TBL] [Abstract][Full Text] [Related]
15. Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus.
Jiang N; Li M; Zhang M; Xu J; Jiang L; Gong L; Wu F; Gu J; Zhao J; Xiang Y; Wang Z; Zhao Y; Zeng X;
PLoS One; 2019; 14(11):e0225516. PubMed ID: 31747435
[TBL] [Abstract][Full Text] [Related]
16. Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China.
Lin H; Wei JC; Tan CY; Liu YY; Li YH; Li FX; Deng DH; Yan B; Liu Y; Zhao Y
Clin Rheumatol; 2012 Dec; 31(12):1683-9. PubMed ID: 22983769
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
18. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
Suszek D; Górak A; Majdan M
Rheumatol Int; 2020 Oct; 40(10):1625-1629. PubMed ID: 32772131
[TBL] [Abstract][Full Text] [Related]
19. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers.
Monzavi SM; Alirezaei A; Shariati-Sarabi Z; Tavakol Afshari J; Mahmoudi M; Dormanesh B; Jahandoost F; Khoshdel AR; Etemad Rezaie A
Inflammopharmacology; 2018 Oct; 26(5):1175-1182. PubMed ID: 29987550
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors and Incidence of Serious Infections in Patients With Systemic Lupus Erythematosus Undergoing Rituximab Therapy.
Sun YS; Huang DF; Chen WS; Liao HT; Chen MH; Tsai MT; Yang CY; Lai CC; Tsai CY
J Rheumatol; 2024 Feb; 51(2):160-167. PubMed ID: 37839817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
